Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Results of operations
  4. 8-K Event Material agreement · Acquisition or sale completed · Executive or director change
  5. 4 Insider Changes in Ownership
  6. 4 Grant or award President & COO acquired 27,714 shares (grant or award)
  7. 4 Returned to the company Former Director returned 1,004 shares (to the company)
  8. 4 Returned to the company Former Director returned 1,004 shares (to the company)
  9. 4 Returned to the company Former Executive Officer returned 11,944 shares (to the company)
  10. 4 Returned to the company Former Executive Officer returned 20,304 shares (to the company)
  11. 4 Returned to the company Former Director returned 1,004 shares (to the company)
  12. 4 Grant or award Chief Executive Officer acquired 45,922 shares (grant or award)
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 8-K Event Other events
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Material agreement
  17. S-3ASR Offering Registration Statement
  18. 4/A Open-market sale Chief Executive Officer sold 1,000 shares at $88.06 ($88,060)
  19. 4 Open-market sale Chief Executive Officer sold 5,000 shares at an average $89.61 ($448,050)
  20. 425 Deal Prospectus/Communication re Business Combination

Page 20 of 115 · 2,300 filings